Treatments Prioritization Working Group

Treatments Prioritization Working Group

OUR ROLE

A multidisciplinary group of experts assigned to evaluate current COVID-19 therapeutic proposals based on a robust and fair methodology.
The group provides scientific advice and guidance to ANRS | EID COVID-19 Scientific Advisory Board in order to support the most promising therapeutic approaches. The overall evaluation is based on scientific evidence along with aspects of transparency and fairness.

The group was recently created in order to help ANRS | EID COVID-19 Scientific Advisory Board to respond efficiently to the increasing number of emerging therapeutic strategies against the COVID-19 pandemic.

The missions of this working group are to:

  • Give advice and scientific support to ANRS | EID COVID-19 SAB.
  • Evaluate under a rigorous and fair methodology the current therapeutic proposals against COVID-19.

Composition

The working group is coordinated by Lionel Piroth – CHU Dijon Bourgogne, and its members are:

Claire Andrejak – CHU Amiens
Roger Le Grand – CEA
Julie Helms – CHRU Strasbourg
Maya Hites – Hôpital Erasme, Bruxelles
Xavier Humbert – CNGE Caen
Xavier de Lamballerie – Inserm, IRD, Université Aix-Marseille
Mathieu Molimard – CHU Bordeaux
Julie Toubiana – Hôpital Necker-Enfants malades, Institut Pasteur
Laurence Weiss – Hôpital Hôtel-Dieu
Mahmoud Zureik – UVSQ, EPI-PHARE